Pharma & Healthcare
Global Dihydropyridine Calcium Channel Blockers Market Research Report 2025
- Jun 23, 25
- ID: 329030
- Pages: 86
- Figures: 90
- Views: 6
The global market for Dihydropyridine Calcium Channel Blockers was valued at US$ 2153 million in the year 2024 and is projected to reach a revised size of US$ 1792 million by 2031, growing at a CAGR of -2.4% during the forecast period.
Dihydropyridine calcium channel blockers (DHP-CCBs) are a class of medications that selectively inhibit L-type calcium channels in vascular smooth muscle, leading to vasodilation and reduced blood pressure. They are primarily used to treat hypertension and angina pectoris. Common agents include amlodipine, nifedipine, and felodipine. DHP-CCBs are known for their strong effect on peripheral vasodilation with minimal impact on cardiac conduction, making them distinct from non-dihydropyridine calcium channel blockers.
North American market for Dihydropyridine Calcium Channel Blockers is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Dihydropyridine Calcium Channel Blockers is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Dihydropyridine Calcium Channel Blockers in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Dihydropyridine Calcium Channel Blockers include Bayer, Huanghai Pharma, Shyndec Pharma, Beijing Hongling Pharma, Ingenus Pharmaceutical, Sine Pharma, AstraZeneca, Lifeon Pharma, Teva, Nanjing Easeheal Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Dihydropyridine Calcium Channel Blockers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dihydropyridine Calcium Channel Blockers.
The Dihydropyridine Calcium Channel Blockers market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dihydropyridine Calcium Channel Blockers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dihydropyridine Calcium Channel Blockers companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Huanghai Pharma
Shyndec Pharma
Beijing Hongling Pharma
Ingenus Pharmaceutical
Sine Pharma
AstraZeneca
Lifeon Pharma
Teva
Nanjing Easeheal Pharma
Novartis
Baxter International
Hikma Pharmaceuticals
Astellas Pharma
Aguettant
Segment by Type
Nifedipine
Iradipine
Felodipine
Nicardipine
Other
Segment by Application
Hospital
Retail Pharmacy
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dihydropyridine Calcium Channel Blockers company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Dihydropyridine calcium channel blockers (DHP-CCBs) are a class of medications that selectively inhibit L-type calcium channels in vascular smooth muscle, leading to vasodilation and reduced blood pressure. They are primarily used to treat hypertension and angina pectoris. Common agents include amlodipine, nifedipine, and felodipine. DHP-CCBs are known for their strong effect on peripheral vasodilation with minimal impact on cardiac conduction, making them distinct from non-dihydropyridine calcium channel blockers.
North American market for Dihydropyridine Calcium Channel Blockers is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Dihydropyridine Calcium Channel Blockers is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Dihydropyridine Calcium Channel Blockers in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Dihydropyridine Calcium Channel Blockers include Bayer, Huanghai Pharma, Shyndec Pharma, Beijing Hongling Pharma, Ingenus Pharmaceutical, Sine Pharma, AstraZeneca, Lifeon Pharma, Teva, Nanjing Easeheal Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Dihydropyridine Calcium Channel Blockers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dihydropyridine Calcium Channel Blockers.
The Dihydropyridine Calcium Channel Blockers market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dihydropyridine Calcium Channel Blockers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dihydropyridine Calcium Channel Blockers companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Huanghai Pharma
Shyndec Pharma
Beijing Hongling Pharma
Ingenus Pharmaceutical
Sine Pharma
AstraZeneca
Lifeon Pharma
Teva
Nanjing Easeheal Pharma
Novartis
Baxter International
Hikma Pharmaceuticals
Astellas Pharma
Aguettant
Segment by Type
Nifedipine
Iradipine
Felodipine
Nicardipine
Other
Segment by Application
Hospital
Retail Pharmacy
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dihydropyridine Calcium Channel Blockers company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dihydropyridine Calcium Channel Blockers Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Nifedipine
1.2.3 Iradipine
1.2.4 Felodipine
1.2.5 Nicardipine
1.2.6 Other
1.3 Market by Application
1.3.1 Global Dihydropyridine Calcium Channel Blockers Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Dihydropyridine Calcium Channel Blockers Market Perspective (2020-2031)
2.2 Global Dihydropyridine Calcium Channel Blockers Growth Trends by Region
2.2.1 Global Dihydropyridine Calcium Channel Blockers Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Dihydropyridine Calcium Channel Blockers Historic Market Size by Region (2020-2025)
2.2.3 Dihydropyridine Calcium Channel Blockers Forecasted Market Size by Region (2026-2031)
2.3 Dihydropyridine Calcium Channel Blockers Market Dynamics
2.3.1 Dihydropyridine Calcium Channel Blockers Industry Trends
2.3.2 Dihydropyridine Calcium Channel Blockers Market Drivers
2.3.3 Dihydropyridine Calcium Channel Blockers Market Challenges
2.3.4 Dihydropyridine Calcium Channel Blockers Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Dihydropyridine Calcium Channel Blockers Players by Revenue
3.1.1 Global Top Dihydropyridine Calcium Channel Blockers Players by Revenue (2020-2025)
3.1.2 Global Dihydropyridine Calcium Channel Blockers Revenue Market Share by Players (2020-2025)
3.2 Global Top Dihydropyridine Calcium Channel Blockers Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Dihydropyridine Calcium Channel Blockers Revenue
3.4 Global Dihydropyridine Calcium Channel Blockers Market Concentration Ratio
3.4.1 Global Dihydropyridine Calcium Channel Blockers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dihydropyridine Calcium Channel Blockers Revenue in 2024
3.5 Global Key Players of Dihydropyridine Calcium Channel Blockers Head office and Area Served
3.6 Global Key Players of Dihydropyridine Calcium Channel Blockers, Product and Application
3.7 Global Key Players of Dihydropyridine Calcium Channel Blockers, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Dihydropyridine Calcium Channel Blockers Breakdown Data by Type
4.1 Global Dihydropyridine Calcium Channel Blockers Historic Market Size by Type (2020-2025)
4.2 Global Dihydropyridine Calcium Channel Blockers Forecasted Market Size by Type (2026-2031)
5 Dihydropyridine Calcium Channel Blockers Breakdown Data by Application
5.1 Global Dihydropyridine Calcium Channel Blockers Historic Market Size by Application (2020-2025)
5.2 Global Dihydropyridine Calcium Channel Blockers Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Dihydropyridine Calcium Channel Blockers Market Size (2020-2031)
6.2 North America Dihydropyridine Calcium Channel Blockers Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Dihydropyridine Calcium Channel Blockers Market Size by Country (2020-2025)
6.4 North America Dihydropyridine Calcium Channel Blockers Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Dihydropyridine Calcium Channel Blockers Market Size (2020-2031)
7.2 Europe Dihydropyridine Calcium Channel Blockers Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Dihydropyridine Calcium Channel Blockers Market Size by Country (2020-2025)
7.4 Europe Dihydropyridine Calcium Channel Blockers Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Dihydropyridine Calcium Channel Blockers Market Size (2020-2031)
8.2 Asia-Pacific Dihydropyridine Calcium Channel Blockers Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Dihydropyridine Calcium Channel Blockers Market Size by Region (2020-2025)
8.4 Asia-Pacific Dihydropyridine Calcium Channel Blockers Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Dihydropyridine Calcium Channel Blockers Market Size (2020-2031)
9.2 Latin America Dihydropyridine Calcium Channel Blockers Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Dihydropyridine Calcium Channel Blockers Market Size by Country (2020-2025)
9.4 Latin America Dihydropyridine Calcium Channel Blockers Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Dihydropyridine Calcium Channel Blockers Market Size (2020-2031)
10.2 Middle East & Africa Dihydropyridine Calcium Channel Blockers Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Dihydropyridine Calcium Channel Blockers Market Size by Country (2020-2025)
10.4 Middle East & Africa Dihydropyridine Calcium Channel Blockers Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Dihydropyridine Calcium Channel Blockers Introduction
11.1.4 Bayer Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
11.1.5 Bayer Recent Development
11.2 Huanghai Pharma
11.2.1 Huanghai Pharma Company Details
11.2.2 Huanghai Pharma Business Overview
11.2.3 Huanghai Pharma Dihydropyridine Calcium Channel Blockers Introduction
11.2.4 Huanghai Pharma Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
11.2.5 Huanghai Pharma Recent Development
11.3 Shyndec Pharma
11.3.1 Shyndec Pharma Company Details
11.3.2 Shyndec Pharma Business Overview
11.3.3 Shyndec Pharma Dihydropyridine Calcium Channel Blockers Introduction
11.3.4 Shyndec Pharma Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
11.3.5 Shyndec Pharma Recent Development
11.4 Beijing Hongling Pharma
11.4.1 Beijing Hongling Pharma Company Details
11.4.2 Beijing Hongling Pharma Business Overview
11.4.3 Beijing Hongling Pharma Dihydropyridine Calcium Channel Blockers Introduction
11.4.4 Beijing Hongling Pharma Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
11.4.5 Beijing Hongling Pharma Recent Development
11.5 Ingenus Pharmaceutical
11.5.1 Ingenus Pharmaceutical Company Details
11.5.2 Ingenus Pharmaceutical Business Overview
11.5.3 Ingenus Pharmaceutical Dihydropyridine Calcium Channel Blockers Introduction
11.5.4 Ingenus Pharmaceutical Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
11.5.5 Ingenus Pharmaceutical Recent Development
11.6 Sine Pharma
11.6.1 Sine Pharma Company Details
11.6.2 Sine Pharma Business Overview
11.6.3 Sine Pharma Dihydropyridine Calcium Channel Blockers Introduction
11.6.4 Sine Pharma Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
11.6.5 Sine Pharma Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Dihydropyridine Calcium Channel Blockers Introduction
11.7.4 AstraZeneca Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
11.7.5 AstraZeneca Recent Development
11.8 Lifeon Pharma
11.8.1 Lifeon Pharma Company Details
11.8.2 Lifeon Pharma Business Overview
11.8.3 Lifeon Pharma Dihydropyridine Calcium Channel Blockers Introduction
11.8.4 Lifeon Pharma Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
11.8.5 Lifeon Pharma Recent Development
11.9 Teva
11.9.1 Teva Company Details
11.9.2 Teva Business Overview
11.9.3 Teva Dihydropyridine Calcium Channel Blockers Introduction
11.9.4 Teva Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
11.9.5 Teva Recent Development
11.10 Nanjing Easeheal Pharma
11.10.1 Nanjing Easeheal Pharma Company Details
11.10.2 Nanjing Easeheal Pharma Business Overview
11.10.3 Nanjing Easeheal Pharma Dihydropyridine Calcium Channel Blockers Introduction
11.10.4 Nanjing Easeheal Pharma Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
11.10.5 Nanjing Easeheal Pharma Recent Development
11.11 Novartis
11.11.1 Novartis Company Details
11.11.2 Novartis Business Overview
11.11.3 Novartis Dihydropyridine Calcium Channel Blockers Introduction
11.11.4 Novartis Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
11.11.5 Novartis Recent Development
11.12 Baxter International
11.12.1 Baxter International Company Details
11.12.2 Baxter International Business Overview
11.12.3 Baxter International Dihydropyridine Calcium Channel Blockers Introduction
11.12.4 Baxter International Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
11.12.5 Baxter International Recent Development
11.13 Hikma Pharmaceuticals
11.13.1 Hikma Pharmaceuticals Company Details
11.13.2 Hikma Pharmaceuticals Business Overview
11.13.3 Hikma Pharmaceuticals Dihydropyridine Calcium Channel Blockers Introduction
11.13.4 Hikma Pharmaceuticals Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
11.13.5 Hikma Pharmaceuticals Recent Development
11.14 Astellas Pharma
11.14.1 Astellas Pharma Company Details
11.14.2 Astellas Pharma Business Overview
11.14.3 Astellas Pharma Dihydropyridine Calcium Channel Blockers Introduction
11.14.4 Astellas Pharma Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
11.14.5 Astellas Pharma Recent Development
11.15 Aguettant
11.15.1 Aguettant Company Details
11.15.2 Aguettant Business Overview
11.15.3 Aguettant Dihydropyridine Calcium Channel Blockers Introduction
11.15.4 Aguettant Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
11.15.5 Aguettant Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dihydropyridine Calcium Channel Blockers Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Nifedipine
1.2.3 Iradipine
1.2.4 Felodipine
1.2.5 Nicardipine
1.2.6 Other
1.3 Market by Application
1.3.1 Global Dihydropyridine Calcium Channel Blockers Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Dihydropyridine Calcium Channel Blockers Market Perspective (2020-2031)
2.2 Global Dihydropyridine Calcium Channel Blockers Growth Trends by Region
2.2.1 Global Dihydropyridine Calcium Channel Blockers Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Dihydropyridine Calcium Channel Blockers Historic Market Size by Region (2020-2025)
2.2.3 Dihydropyridine Calcium Channel Blockers Forecasted Market Size by Region (2026-2031)
2.3 Dihydropyridine Calcium Channel Blockers Market Dynamics
2.3.1 Dihydropyridine Calcium Channel Blockers Industry Trends
2.3.2 Dihydropyridine Calcium Channel Blockers Market Drivers
2.3.3 Dihydropyridine Calcium Channel Blockers Market Challenges
2.3.4 Dihydropyridine Calcium Channel Blockers Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Dihydropyridine Calcium Channel Blockers Players by Revenue
3.1.1 Global Top Dihydropyridine Calcium Channel Blockers Players by Revenue (2020-2025)
3.1.2 Global Dihydropyridine Calcium Channel Blockers Revenue Market Share by Players (2020-2025)
3.2 Global Top Dihydropyridine Calcium Channel Blockers Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Dihydropyridine Calcium Channel Blockers Revenue
3.4 Global Dihydropyridine Calcium Channel Blockers Market Concentration Ratio
3.4.1 Global Dihydropyridine Calcium Channel Blockers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dihydropyridine Calcium Channel Blockers Revenue in 2024
3.5 Global Key Players of Dihydropyridine Calcium Channel Blockers Head office and Area Served
3.6 Global Key Players of Dihydropyridine Calcium Channel Blockers, Product and Application
3.7 Global Key Players of Dihydropyridine Calcium Channel Blockers, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Dihydropyridine Calcium Channel Blockers Breakdown Data by Type
4.1 Global Dihydropyridine Calcium Channel Blockers Historic Market Size by Type (2020-2025)
4.2 Global Dihydropyridine Calcium Channel Blockers Forecasted Market Size by Type (2026-2031)
5 Dihydropyridine Calcium Channel Blockers Breakdown Data by Application
5.1 Global Dihydropyridine Calcium Channel Blockers Historic Market Size by Application (2020-2025)
5.2 Global Dihydropyridine Calcium Channel Blockers Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Dihydropyridine Calcium Channel Blockers Market Size (2020-2031)
6.2 North America Dihydropyridine Calcium Channel Blockers Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Dihydropyridine Calcium Channel Blockers Market Size by Country (2020-2025)
6.4 North America Dihydropyridine Calcium Channel Blockers Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Dihydropyridine Calcium Channel Blockers Market Size (2020-2031)
7.2 Europe Dihydropyridine Calcium Channel Blockers Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Dihydropyridine Calcium Channel Blockers Market Size by Country (2020-2025)
7.4 Europe Dihydropyridine Calcium Channel Blockers Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Dihydropyridine Calcium Channel Blockers Market Size (2020-2031)
8.2 Asia-Pacific Dihydropyridine Calcium Channel Blockers Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Dihydropyridine Calcium Channel Blockers Market Size by Region (2020-2025)
8.4 Asia-Pacific Dihydropyridine Calcium Channel Blockers Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Dihydropyridine Calcium Channel Blockers Market Size (2020-2031)
9.2 Latin America Dihydropyridine Calcium Channel Blockers Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Dihydropyridine Calcium Channel Blockers Market Size by Country (2020-2025)
9.4 Latin America Dihydropyridine Calcium Channel Blockers Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Dihydropyridine Calcium Channel Blockers Market Size (2020-2031)
10.2 Middle East & Africa Dihydropyridine Calcium Channel Blockers Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Dihydropyridine Calcium Channel Blockers Market Size by Country (2020-2025)
10.4 Middle East & Africa Dihydropyridine Calcium Channel Blockers Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Dihydropyridine Calcium Channel Blockers Introduction
11.1.4 Bayer Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
11.1.5 Bayer Recent Development
11.2 Huanghai Pharma
11.2.1 Huanghai Pharma Company Details
11.2.2 Huanghai Pharma Business Overview
11.2.3 Huanghai Pharma Dihydropyridine Calcium Channel Blockers Introduction
11.2.4 Huanghai Pharma Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
11.2.5 Huanghai Pharma Recent Development
11.3 Shyndec Pharma
11.3.1 Shyndec Pharma Company Details
11.3.2 Shyndec Pharma Business Overview
11.3.3 Shyndec Pharma Dihydropyridine Calcium Channel Blockers Introduction
11.3.4 Shyndec Pharma Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
11.3.5 Shyndec Pharma Recent Development
11.4 Beijing Hongling Pharma
11.4.1 Beijing Hongling Pharma Company Details
11.4.2 Beijing Hongling Pharma Business Overview
11.4.3 Beijing Hongling Pharma Dihydropyridine Calcium Channel Blockers Introduction
11.4.4 Beijing Hongling Pharma Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
11.4.5 Beijing Hongling Pharma Recent Development
11.5 Ingenus Pharmaceutical
11.5.1 Ingenus Pharmaceutical Company Details
11.5.2 Ingenus Pharmaceutical Business Overview
11.5.3 Ingenus Pharmaceutical Dihydropyridine Calcium Channel Blockers Introduction
11.5.4 Ingenus Pharmaceutical Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
11.5.5 Ingenus Pharmaceutical Recent Development
11.6 Sine Pharma
11.6.1 Sine Pharma Company Details
11.6.2 Sine Pharma Business Overview
11.6.3 Sine Pharma Dihydropyridine Calcium Channel Blockers Introduction
11.6.4 Sine Pharma Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
11.6.5 Sine Pharma Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Dihydropyridine Calcium Channel Blockers Introduction
11.7.4 AstraZeneca Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
11.7.5 AstraZeneca Recent Development
11.8 Lifeon Pharma
11.8.1 Lifeon Pharma Company Details
11.8.2 Lifeon Pharma Business Overview
11.8.3 Lifeon Pharma Dihydropyridine Calcium Channel Blockers Introduction
11.8.4 Lifeon Pharma Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
11.8.5 Lifeon Pharma Recent Development
11.9 Teva
11.9.1 Teva Company Details
11.9.2 Teva Business Overview
11.9.3 Teva Dihydropyridine Calcium Channel Blockers Introduction
11.9.4 Teva Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
11.9.5 Teva Recent Development
11.10 Nanjing Easeheal Pharma
11.10.1 Nanjing Easeheal Pharma Company Details
11.10.2 Nanjing Easeheal Pharma Business Overview
11.10.3 Nanjing Easeheal Pharma Dihydropyridine Calcium Channel Blockers Introduction
11.10.4 Nanjing Easeheal Pharma Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
11.10.5 Nanjing Easeheal Pharma Recent Development
11.11 Novartis
11.11.1 Novartis Company Details
11.11.2 Novartis Business Overview
11.11.3 Novartis Dihydropyridine Calcium Channel Blockers Introduction
11.11.4 Novartis Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
11.11.5 Novartis Recent Development
11.12 Baxter International
11.12.1 Baxter International Company Details
11.12.2 Baxter International Business Overview
11.12.3 Baxter International Dihydropyridine Calcium Channel Blockers Introduction
11.12.4 Baxter International Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
11.12.5 Baxter International Recent Development
11.13 Hikma Pharmaceuticals
11.13.1 Hikma Pharmaceuticals Company Details
11.13.2 Hikma Pharmaceuticals Business Overview
11.13.3 Hikma Pharmaceuticals Dihydropyridine Calcium Channel Blockers Introduction
11.13.4 Hikma Pharmaceuticals Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
11.13.5 Hikma Pharmaceuticals Recent Development
11.14 Astellas Pharma
11.14.1 Astellas Pharma Company Details
11.14.2 Astellas Pharma Business Overview
11.14.3 Astellas Pharma Dihydropyridine Calcium Channel Blockers Introduction
11.14.4 Astellas Pharma Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
11.14.5 Astellas Pharma Recent Development
11.15 Aguettant
11.15.1 Aguettant Company Details
11.15.2 Aguettant Business Overview
11.15.3 Aguettant Dihydropyridine Calcium Channel Blockers Introduction
11.15.4 Aguettant Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
11.15.5 Aguettant Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Dihydropyridine Calcium Channel Blockers Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Nifedipine
Table 3. Key Players of Iradipine
Table 4. Key Players of Felodipine
Table 5. Key Players of Nicardipine
Table 6. Key Players of Other
Table 7. Global Dihydropyridine Calcium Channel Blockers Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Dihydropyridine Calcium Channel Blockers Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Dihydropyridine Calcium Channel Blockers Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Dihydropyridine Calcium Channel Blockers Market Share by Region (2020-2025)
Table 11. Global Dihydropyridine Calcium Channel Blockers Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Dihydropyridine Calcium Channel Blockers Market Share by Region (2026-2031)
Table 13. Dihydropyridine Calcium Channel Blockers Market Trends
Table 14. Dihydropyridine Calcium Channel Blockers Market Drivers
Table 15. Dihydropyridine Calcium Channel Blockers Market Challenges
Table 16. Dihydropyridine Calcium Channel Blockers Market Restraints
Table 17. Global Dihydropyridine Calcium Channel Blockers Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Dihydropyridine Calcium Channel Blockers Market Share by Players (2020-2025)
Table 19. Global Top Dihydropyridine Calcium Channel Blockers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dihydropyridine Calcium Channel Blockers as of 2024)
Table 20. Ranking of Global Top Dihydropyridine Calcium Channel Blockers Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Dihydropyridine Calcium Channel Blockers Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Dihydropyridine Calcium Channel Blockers, Headquarters and Area Served
Table 23. Global Key Players of Dihydropyridine Calcium Channel Blockers, Product and Application
Table 24. Global Key Players of Dihydropyridine Calcium Channel Blockers, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Dihydropyridine Calcium Channel Blockers Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Dihydropyridine Calcium Channel Blockers Revenue Market Share by Type (2020-2025)
Table 28. Global Dihydropyridine Calcium Channel Blockers Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Dihydropyridine Calcium Channel Blockers Revenue Market Share by Type (2026-2031)
Table 30. Global Dihydropyridine Calcium Channel Blockers Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Dihydropyridine Calcium Channel Blockers Revenue Market Share by Application (2020-2025)
Table 32. Global Dihydropyridine Calcium Channel Blockers Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Dihydropyridine Calcium Channel Blockers Revenue Market Share by Application (2026-2031)
Table 34. North America Dihydropyridine Calcium Channel Blockers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Dihydropyridine Calcium Channel Blockers Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Dihydropyridine Calcium Channel Blockers Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Dihydropyridine Calcium Channel Blockers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Dihydropyridine Calcium Channel Blockers Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Dihydropyridine Calcium Channel Blockers Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Dihydropyridine Calcium Channel Blockers Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Dihydropyridine Calcium Channel Blockers Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Dihydropyridine Calcium Channel Blockers Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Dihydropyridine Calcium Channel Blockers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Dihydropyridine Calcium Channel Blockers Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Dihydropyridine Calcium Channel Blockers Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Dihydropyridine Calcium Channel Blockers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Dihydropyridine Calcium Channel Blockers Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Dihydropyridine Calcium Channel Blockers Market Size by Country (2026-2031) & (US$ Million)
Table 49. Bayer Company Details
Table 50. Bayer Business Overview
Table 51. Bayer Dihydropyridine Calcium Channel Blockers Product
Table 52. Bayer Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025) & (US$ Million)
Table 53. Bayer Recent Development
Table 54. Huanghai Pharma Company Details
Table 55. Huanghai Pharma Business Overview
Table 56. Huanghai Pharma Dihydropyridine Calcium Channel Blockers Product
Table 57. Huanghai Pharma Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025) & (US$ Million)
Table 58. Huanghai Pharma Recent Development
Table 59. Shyndec Pharma Company Details
Table 60. Shyndec Pharma Business Overview
Table 61. Shyndec Pharma Dihydropyridine Calcium Channel Blockers Product
Table 62. Shyndec Pharma Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025) & (US$ Million)
Table 63. Shyndec Pharma Recent Development
Table 64. Beijing Hongling Pharma Company Details
Table 65. Beijing Hongling Pharma Business Overview
Table 66. Beijing Hongling Pharma Dihydropyridine Calcium Channel Blockers Product
Table 67. Beijing Hongling Pharma Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025) & (US$ Million)
Table 68. Beijing Hongling Pharma Recent Development
Table 69. Ingenus Pharmaceutical Company Details
Table 70. Ingenus Pharmaceutical Business Overview
Table 71. Ingenus Pharmaceutical Dihydropyridine Calcium Channel Blockers Product
Table 72. Ingenus Pharmaceutical Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025) & (US$ Million)
Table 73. Ingenus Pharmaceutical Recent Development
Table 74. Sine Pharma Company Details
Table 75. Sine Pharma Business Overview
Table 76. Sine Pharma Dihydropyridine Calcium Channel Blockers Product
Table 77. Sine Pharma Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025) & (US$ Million)
Table 78. Sine Pharma Recent Development
Table 79. AstraZeneca Company Details
Table 80. AstraZeneca Business Overview
Table 81. AstraZeneca Dihydropyridine Calcium Channel Blockers Product
Table 82. AstraZeneca Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025) & (US$ Million)
Table 83. AstraZeneca Recent Development
Table 84. Lifeon Pharma Company Details
Table 85. Lifeon Pharma Business Overview
Table 86. Lifeon Pharma Dihydropyridine Calcium Channel Blockers Product
Table 87. Lifeon Pharma Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025) & (US$ Million)
Table 88. Lifeon Pharma Recent Development
Table 89. Teva Company Details
Table 90. Teva Business Overview
Table 91. Teva Dihydropyridine Calcium Channel Blockers Product
Table 92. Teva Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025) & (US$ Million)
Table 93. Teva Recent Development
Table 94. Nanjing Easeheal Pharma Company Details
Table 95. Nanjing Easeheal Pharma Business Overview
Table 96. Nanjing Easeheal Pharma Dihydropyridine Calcium Channel Blockers Product
Table 97. Nanjing Easeheal Pharma Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025) & (US$ Million)
Table 98. Nanjing Easeheal Pharma Recent Development
Table 99. Novartis Company Details
Table 100. Novartis Business Overview
Table 101. Novartis Dihydropyridine Calcium Channel Blockers Product
Table 102. Novartis Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025) & (US$ Million)
Table 103. Novartis Recent Development
Table 104. Baxter International Company Details
Table 105. Baxter International Business Overview
Table 106. Baxter International Dihydropyridine Calcium Channel Blockers Product
Table 107. Baxter International Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025) & (US$ Million)
Table 108. Baxter International Recent Development
Table 109. Hikma Pharmaceuticals Company Details
Table 110. Hikma Pharmaceuticals Business Overview
Table 111. Hikma Pharmaceuticals Dihydropyridine Calcium Channel Blockers Product
Table 112. Hikma Pharmaceuticals Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025) & (US$ Million)
Table 113. Hikma Pharmaceuticals Recent Development
Table 114. Astellas Pharma Company Details
Table 115. Astellas Pharma Business Overview
Table 116. Astellas Pharma Dihydropyridine Calcium Channel Blockers Product
Table 117. Astellas Pharma Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025) & (US$ Million)
Table 118. Astellas Pharma Recent Development
Table 119. Aguettant Company Details
Table 120. Aguettant Business Overview
Table 121. Aguettant Dihydropyridine Calcium Channel Blockers Product
Table 122. Aguettant Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025) & (US$ Million)
Table 123. Aguettant Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
Table 127. Authors List of This Report
List of Figures
Figure 1. Dihydropyridine Calcium Channel Blockers Picture
Figure 2. Global Dihydropyridine Calcium Channel Blockers Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Dihydropyridine Calcium Channel Blockers Market Share by Type: 2024 VS 2031
Figure 4. Nifedipine Features
Figure 5. Iradipine Features
Figure 6. Felodipine Features
Figure 7. Nicardipine Features
Figure 8. Other Features
Figure 9. Global Dihydropyridine Calcium Channel Blockers Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Dihydropyridine Calcium Channel Blockers Market Share by Application: 2024 VS 2031
Figure 11. Hospital Case Studies
Figure 12. Retail Pharmacy Case Studies
Figure 13. Other Case Studies
Figure 14. Dihydropyridine Calcium Channel Blockers Report Years Considered
Figure 15. Global Dihydropyridine Calcium Channel Blockers Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Dihydropyridine Calcium Channel Blockers Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Dihydropyridine Calcium Channel Blockers Market Share by Region: 2024 VS 2031
Figure 18. Global Dihydropyridine Calcium Channel Blockers Market Share by Players in 2024
Figure 19. Global Dihydropyridine Calcium Channel Blockers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. The Top 10 and 5 Players Market Share by Dihydropyridine Calcium Channel Blockers Revenue in 2024
Figure 21. North America Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Dihydropyridine Calcium Channel Blockers Market Share by Country (2020-2031)
Figure 23. United States Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Dihydropyridine Calcium Channel Blockers Market Share by Country (2020-2031)
Figure 27. Germany Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Ireland Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Dihydropyridine Calcium Channel Blockers Market Share by Region (2020-2031)
Figure 35. China Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia & New Zealand Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Dihydropyridine Calcium Channel Blockers Market Share by Country (2020-2031)
Figure 43. Mexico Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Dihydropyridine Calcium Channel Blockers Market Share by Country (2020-2031)
Figure 47. Israel Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Bayer Revenue Growth Rate in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
Figure 51. Huanghai Pharma Revenue Growth Rate in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
Figure 52. Shyndec Pharma Revenue Growth Rate in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
Figure 53. Beijing Hongling Pharma Revenue Growth Rate in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
Figure 54. Ingenus Pharmaceutical Revenue Growth Rate in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
Figure 55. Sine Pharma Revenue Growth Rate in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
Figure 56. AstraZeneca Revenue Growth Rate in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
Figure 57. Lifeon Pharma Revenue Growth Rate in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
Figure 58. Teva Revenue Growth Rate in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
Figure 59. Nanjing Easeheal Pharma Revenue Growth Rate in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
Figure 60. Novartis Revenue Growth Rate in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
Figure 61. Baxter International Revenue Growth Rate in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
Figure 62. Hikma Pharmaceuticals Revenue Growth Rate in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
Figure 63. Astellas Pharma Revenue Growth Rate in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
Figure 64. Aguettant Revenue Growth Rate in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Table 1. Global Dihydropyridine Calcium Channel Blockers Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Nifedipine
Table 3. Key Players of Iradipine
Table 4. Key Players of Felodipine
Table 5. Key Players of Nicardipine
Table 6. Key Players of Other
Table 7. Global Dihydropyridine Calcium Channel Blockers Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Dihydropyridine Calcium Channel Blockers Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Dihydropyridine Calcium Channel Blockers Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Dihydropyridine Calcium Channel Blockers Market Share by Region (2020-2025)
Table 11. Global Dihydropyridine Calcium Channel Blockers Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Dihydropyridine Calcium Channel Blockers Market Share by Region (2026-2031)
Table 13. Dihydropyridine Calcium Channel Blockers Market Trends
Table 14. Dihydropyridine Calcium Channel Blockers Market Drivers
Table 15. Dihydropyridine Calcium Channel Blockers Market Challenges
Table 16. Dihydropyridine Calcium Channel Blockers Market Restraints
Table 17. Global Dihydropyridine Calcium Channel Blockers Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Dihydropyridine Calcium Channel Blockers Market Share by Players (2020-2025)
Table 19. Global Top Dihydropyridine Calcium Channel Blockers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dihydropyridine Calcium Channel Blockers as of 2024)
Table 20. Ranking of Global Top Dihydropyridine Calcium Channel Blockers Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Dihydropyridine Calcium Channel Blockers Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Dihydropyridine Calcium Channel Blockers, Headquarters and Area Served
Table 23. Global Key Players of Dihydropyridine Calcium Channel Blockers, Product and Application
Table 24. Global Key Players of Dihydropyridine Calcium Channel Blockers, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Dihydropyridine Calcium Channel Blockers Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Dihydropyridine Calcium Channel Blockers Revenue Market Share by Type (2020-2025)
Table 28. Global Dihydropyridine Calcium Channel Blockers Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Dihydropyridine Calcium Channel Blockers Revenue Market Share by Type (2026-2031)
Table 30. Global Dihydropyridine Calcium Channel Blockers Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Dihydropyridine Calcium Channel Blockers Revenue Market Share by Application (2020-2025)
Table 32. Global Dihydropyridine Calcium Channel Blockers Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Dihydropyridine Calcium Channel Blockers Revenue Market Share by Application (2026-2031)
Table 34. North America Dihydropyridine Calcium Channel Blockers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Dihydropyridine Calcium Channel Blockers Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Dihydropyridine Calcium Channel Blockers Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Dihydropyridine Calcium Channel Blockers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Dihydropyridine Calcium Channel Blockers Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Dihydropyridine Calcium Channel Blockers Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Dihydropyridine Calcium Channel Blockers Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Dihydropyridine Calcium Channel Blockers Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Dihydropyridine Calcium Channel Blockers Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Dihydropyridine Calcium Channel Blockers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Dihydropyridine Calcium Channel Blockers Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Dihydropyridine Calcium Channel Blockers Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Dihydropyridine Calcium Channel Blockers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Dihydropyridine Calcium Channel Blockers Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Dihydropyridine Calcium Channel Blockers Market Size by Country (2026-2031) & (US$ Million)
Table 49. Bayer Company Details
Table 50. Bayer Business Overview
Table 51. Bayer Dihydropyridine Calcium Channel Blockers Product
Table 52. Bayer Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025) & (US$ Million)
Table 53. Bayer Recent Development
Table 54. Huanghai Pharma Company Details
Table 55. Huanghai Pharma Business Overview
Table 56. Huanghai Pharma Dihydropyridine Calcium Channel Blockers Product
Table 57. Huanghai Pharma Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025) & (US$ Million)
Table 58. Huanghai Pharma Recent Development
Table 59. Shyndec Pharma Company Details
Table 60. Shyndec Pharma Business Overview
Table 61. Shyndec Pharma Dihydropyridine Calcium Channel Blockers Product
Table 62. Shyndec Pharma Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025) & (US$ Million)
Table 63. Shyndec Pharma Recent Development
Table 64. Beijing Hongling Pharma Company Details
Table 65. Beijing Hongling Pharma Business Overview
Table 66. Beijing Hongling Pharma Dihydropyridine Calcium Channel Blockers Product
Table 67. Beijing Hongling Pharma Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025) & (US$ Million)
Table 68. Beijing Hongling Pharma Recent Development
Table 69. Ingenus Pharmaceutical Company Details
Table 70. Ingenus Pharmaceutical Business Overview
Table 71. Ingenus Pharmaceutical Dihydropyridine Calcium Channel Blockers Product
Table 72. Ingenus Pharmaceutical Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025) & (US$ Million)
Table 73. Ingenus Pharmaceutical Recent Development
Table 74. Sine Pharma Company Details
Table 75. Sine Pharma Business Overview
Table 76. Sine Pharma Dihydropyridine Calcium Channel Blockers Product
Table 77. Sine Pharma Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025) & (US$ Million)
Table 78. Sine Pharma Recent Development
Table 79. AstraZeneca Company Details
Table 80. AstraZeneca Business Overview
Table 81. AstraZeneca Dihydropyridine Calcium Channel Blockers Product
Table 82. AstraZeneca Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025) & (US$ Million)
Table 83. AstraZeneca Recent Development
Table 84. Lifeon Pharma Company Details
Table 85. Lifeon Pharma Business Overview
Table 86. Lifeon Pharma Dihydropyridine Calcium Channel Blockers Product
Table 87. Lifeon Pharma Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025) & (US$ Million)
Table 88. Lifeon Pharma Recent Development
Table 89. Teva Company Details
Table 90. Teva Business Overview
Table 91. Teva Dihydropyridine Calcium Channel Blockers Product
Table 92. Teva Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025) & (US$ Million)
Table 93. Teva Recent Development
Table 94. Nanjing Easeheal Pharma Company Details
Table 95. Nanjing Easeheal Pharma Business Overview
Table 96. Nanjing Easeheal Pharma Dihydropyridine Calcium Channel Blockers Product
Table 97. Nanjing Easeheal Pharma Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025) & (US$ Million)
Table 98. Nanjing Easeheal Pharma Recent Development
Table 99. Novartis Company Details
Table 100. Novartis Business Overview
Table 101. Novartis Dihydropyridine Calcium Channel Blockers Product
Table 102. Novartis Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025) & (US$ Million)
Table 103. Novartis Recent Development
Table 104. Baxter International Company Details
Table 105. Baxter International Business Overview
Table 106. Baxter International Dihydropyridine Calcium Channel Blockers Product
Table 107. Baxter International Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025) & (US$ Million)
Table 108. Baxter International Recent Development
Table 109. Hikma Pharmaceuticals Company Details
Table 110. Hikma Pharmaceuticals Business Overview
Table 111. Hikma Pharmaceuticals Dihydropyridine Calcium Channel Blockers Product
Table 112. Hikma Pharmaceuticals Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025) & (US$ Million)
Table 113. Hikma Pharmaceuticals Recent Development
Table 114. Astellas Pharma Company Details
Table 115. Astellas Pharma Business Overview
Table 116. Astellas Pharma Dihydropyridine Calcium Channel Blockers Product
Table 117. Astellas Pharma Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025) & (US$ Million)
Table 118. Astellas Pharma Recent Development
Table 119. Aguettant Company Details
Table 120. Aguettant Business Overview
Table 121. Aguettant Dihydropyridine Calcium Channel Blockers Product
Table 122. Aguettant Revenue in Dihydropyridine Calcium Channel Blockers Business (2020-2025) & (US$ Million)
Table 123. Aguettant Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
Table 127. Authors List of This Report
List of Figures
Figure 1. Dihydropyridine Calcium Channel Blockers Picture
Figure 2. Global Dihydropyridine Calcium Channel Blockers Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Dihydropyridine Calcium Channel Blockers Market Share by Type: 2024 VS 2031
Figure 4. Nifedipine Features
Figure 5. Iradipine Features
Figure 6. Felodipine Features
Figure 7. Nicardipine Features
Figure 8. Other Features
Figure 9. Global Dihydropyridine Calcium Channel Blockers Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Dihydropyridine Calcium Channel Blockers Market Share by Application: 2024 VS 2031
Figure 11. Hospital Case Studies
Figure 12. Retail Pharmacy Case Studies
Figure 13. Other Case Studies
Figure 14. Dihydropyridine Calcium Channel Blockers Report Years Considered
Figure 15. Global Dihydropyridine Calcium Channel Blockers Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Dihydropyridine Calcium Channel Blockers Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Dihydropyridine Calcium Channel Blockers Market Share by Region: 2024 VS 2031
Figure 18. Global Dihydropyridine Calcium Channel Blockers Market Share by Players in 2024
Figure 19. Global Dihydropyridine Calcium Channel Blockers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. The Top 10 and 5 Players Market Share by Dihydropyridine Calcium Channel Blockers Revenue in 2024
Figure 21. North America Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Dihydropyridine Calcium Channel Blockers Market Share by Country (2020-2031)
Figure 23. United States Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Dihydropyridine Calcium Channel Blockers Market Share by Country (2020-2031)
Figure 27. Germany Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Ireland Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Dihydropyridine Calcium Channel Blockers Market Share by Region (2020-2031)
Figure 35. China Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia & New Zealand Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Dihydropyridine Calcium Channel Blockers Market Share by Country (2020-2031)
Figure 43. Mexico Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Dihydropyridine Calcium Channel Blockers Market Share by Country (2020-2031)
Figure 47. Israel Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Dihydropyridine Calcium Channel Blockers Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Bayer Revenue Growth Rate in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
Figure 51. Huanghai Pharma Revenue Growth Rate in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
Figure 52. Shyndec Pharma Revenue Growth Rate in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
Figure 53. Beijing Hongling Pharma Revenue Growth Rate in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
Figure 54. Ingenus Pharmaceutical Revenue Growth Rate in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
Figure 55. Sine Pharma Revenue Growth Rate in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
Figure 56. AstraZeneca Revenue Growth Rate in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
Figure 57. Lifeon Pharma Revenue Growth Rate in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
Figure 58. Teva Revenue Growth Rate in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
Figure 59. Nanjing Easeheal Pharma Revenue Growth Rate in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
Figure 60. Novartis Revenue Growth Rate in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
Figure 61. Baxter International Revenue Growth Rate in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
Figure 62. Hikma Pharmaceuticals Revenue Growth Rate in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
Figure 63. Astellas Pharma Revenue Growth Rate in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
Figure 64. Aguettant Revenue Growth Rate in Dihydropyridine Calcium Channel Blockers Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232